|Bid||0.00 x 1800|
|Ask||0.00 x 1800|
|Day's Range||11.91 - 12.62|
|52 Week Range||9.09 - 17.98|
|Beta (3Y Monthly)||2.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.27|
NEW YORK, April 24, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
NEW YORK, NY / ACCESSWIRE / April 24, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review ...
NEW YORK, NY / ACCESSWIRE / April 23, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Mattel, Inc.(''Mattel'' or the ''Company'') (MAT) and certain of its officers and directors. The class action, filed in United States District Court, Central District of California, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who acquired Mattel securities between February 7, 2019, and February 15, 2019, inclusive (the ''Class Period''), seeking to pursue remedies under the Securities Exchange Act of 1934 (the ''Exchange Act''). If you are a shareholder who purchased Mattel securities between February 7, 2019, and February 15, 2019, you have until May 6, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.
The vast majority of the time in a wishy-washy market environment like the one we're in now, "buying the dips and selling the rips" is an appropriate strategy. Traders can count on a reversal when a rally or meltdown becomes overextended.In some cases, though, a sharp stumble isn't necessarily a buying opportunity. Rather, it's a glimpse at the shape of things to come, with investors only beginning to file out of an equity.With that as the backdrop, here's a closer look at 10 oversold stocks to sell rather than scoop up at their currently depressed prices. While investors should remain on guard for rebounds inspired by bargain-hunters expecting the reversals we'd normally see in such situations, in all of these cases we've seen a handful of red flags suggesting things could get worse before that get better.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 High-Yielding Dividend Stocks That Won't Wilt In no particular order… Stocks to Sell: J B Hunt Transport Services (JBHT)It wasn't a disastrous quarter, but last quarter's numbers from J B Hunt Transport Services (NASDAQ:JBHT) were far from being impressive. More than that, they may be a microcosm of a bigger headwind that's now blowing.One issue, ironically, is that the economy is so strong and jobs are so plentiful, trucking companies like J B Hunt are struggling to find and keep drivers. Then there's slowing demand for intermodal transportation, mostly crimped by trade friction between the U.S. and China. Earnings of $1.09 per share fell short of the $1.26 analysts were expecting.That lackluster future is still being priced into the chart. Though down by nearly one-fourth since June's peak, JBHT shares have yet to slide back to a long-term support line, currently at $83. The current trend pushing shares that direction has plenty of momentum too. Mattel (MAT)To its credit, toymaker Mattel (NASDAQ:MAT) has done its best to adapt to an electronic, digital world. In January, Chief Technology Officer Sven Gerjets demonstrated the company's deep understanding that the future is 'phygital' … the melding of traditional physical toys with computerized technology. The company is thinking aggressively about media tie-ins too, reportedly planning a live-action film featuring Mattel's beloved Barbie doll. * 7 Tech Stocks With Too Much Risk, Not Enough Upside For whatever reason, though, nothing really seems to be clicking for the once-iconic company. Though MAT stock looked like it would finally work out a reversal after December's hard landing, the selling that got started back in 2014 has been renewed this month. The stock is down nearly 70% from the peak made five years ago, and once again within easy reach of multi-year lows. Gilead Sciences (GILD)When Gilead Sciences (NASDAQ:GILD) shares tumbled in 2016, investors largely knew why. An amazing run in 2013 and 2014 stemming from sky-high prices of its hepatitis C drugs Harvoni and Sovaldi -- which were effectively 'cures' -- were about to be challenged by cheaper competitors as well as social outrage over their needlessly high price tag.By early 2017, though, investors figured the worst had been priced in and assumed Gilead would properly regroup for the road ahead.That hasn't turned out to be the case though. GILD stock has been steadily trending lower since its early 2018 high, and if shares break below a technical floor right around $60, this oversold name will most definitely become one of a handful of stocks to sell.In short, Gilead Sciences simply isn't holding up to its competition. Nordstrom (JWN)It's sometimes difficult to tell given the number of store closing we're still seeing, but the so-called retail apocalypse is abating. That's a big reason Nordstrom (NYSE:JWN) rallied in 2018. For a short while, it appeared as if the upper-end chain of stores would emerge from the industry-wide meltdown as healthy as it has ever been.It's now clear, however, that while not as brutal, the retail apocalypse is still underway, and still plaguing some slivers of the business more than others. Last quarter's total top line of $4.48 billion was not only down from the year-ago tally of $4.7 billion, it also fell short of the $4.61 billion analysts were expecting. Same-store sales at its full-priced venues was a scant 0.1%. * 5 Dividend Stocks Perfect for Retirees JWN is already one of several oversold stocks in the sector. But, if it breaks below the support line that tagged the 2016 and 2017 lows, it will earn a spot on a short list of stocks to sell. Wells Fargo (WFC)Wells Fargo (NYSE:WFC), to be clear, is mostly suffering from self-inflicted wounds. The 2016 account-opening scandal led to backlash from multiple directions ever since.The public -- consumers -- was at least willing to forgive if not outright forget. A surprising string of quarterly results carried WFC stock to record highs by early 2018.That's when regulators really started to sink their teeth into the company's hide though. Among other things, the mega bank in August was charged more than $2 billion for making improper mortgage loans. The clincher, however, is the fact the Federal Reserve has capped the company's permitted assets it can leave on the books, essentially capping earnings growth. The company doesn't believe that growth ban will be lifted anytime this year.With little to look forward to, WFC shares are in a well-developed downtrend that probably won't find a firm floor until it reaches the $41 area. L Brands (LB)L Brands (NYSE:LB) shares are down a stunning 69% from their late-2015 peak, and that downtrend is still going strong. The stock is only a few pennies away from new multiyear lows, and given its bearish momentum, odds are good it will once again slide deeper into the red.L Brands, of course, is the parent company of Victoria's Secret and Bath & Body Works … two powerhouses in the heyday of mall shopping, but two venues that are struggling to connect with consumers in a digital world where shoppers splurge in different ways. While revenue growth remains steady, quarterly operating income has been reliably shrinking since early 2016 as L Brands has to spend more and more to keep patrons coming to its stores. And even then, things are tough. Fourth-quarter same-store sales excluding e-commerce spending was down 1%, extending a concerning streak of backpedaling. * 10 S&P 500 Stocks to Weather the Earnings Storm In that light, the stock's long-term downtrend makes sense. AbbVie (ABBV)AbbVie (NYSE:ABBV) was a heroic performer in 2017, rallying from $57 to an early 2018 peak near $117, mostly driven by impressive sales growth from Humira as well as Imbruvica. The former's revenue was up 14.4% that year, and the latter's grew more than 40%.The big run-up only set up a sizable fall though, spurred not by slowing revenue growth, but an impending and inevitable threat to its Humira franchise.The company has been maneuvering for years to maintain the patent on its flagship drug Humira, to be clear, which generated nearly $20 billion in revenue last year. But, time is ultimately working against AbbVie. Earlier this month six separate lawsuits were filed against the pharmaceutical giant, each making the same basic claim … that biosimilars of Humira should already be allowed in the United States.Investors appear to know the company won't be able to fend off these legal arguments for much longer. Nektar Therapeutics (NKTR)In late 2017, the Nektar Therapeutics (NASDAQ:NKTR) rally was unstoppable. Eli Lilly (NYSE:LLY) had made an upfront cash payment to the company in exchange for development and participation rights in T-cell booster NKTR-358, and at the same time posted big-time third quarter revenue growth.As is so often the case in the biopharma arena, though, excited investors overestimated what was to come, and how quickly that would take shape. In June of last year a trial of cancer therapy NKTR-214 led to lackluster results, and in February the company once again reported just so-so outcomes with the same drug in use as a therapy for a different form of cancer. * 7 Stocks to Buy for Spring Season Growth Nektar Therapeutics shares have fallen more than 70% since their early 2018 high, and are pennies away from breaking below an established support level of right around $30. HP (HPQ)After a brief stumble in 2015 when it split with the enterprise-oriented half of the company Hewlett Packard Enterprise (NYSE:HPE) to focus on consumer-level computers and printers, HP (NYSE:HPQ) started what would turn into a solid, multiyear advance. The early-2016 low near $8 gave way to a move to 2018's peak near $27, partially driven by steadying PC sales, and partially prompted by an improving economy.That 2018 peak, however, has also become a perfect pivot. Since then HPQ shares have logged a lower major low and lower major high, and as of this week appear to be aiming at a new 52-week low. Traders aren't buying on the dip -- at least not in earnest -- now that the bullish trend lines of yesteryear have been snapped. Davita (DVA)Finally, add Davita (NYSE:DVA) to your list of oversold stocks to sell rather than buy. Though down 36% from its early 2018 high, there's still room and reason for it to continue sinking.It may not be a household name, but it may ring a bell all the same. Davita is a chain of kidney care and dialysis centers that for years had been one of Warren Buffett's favorite stock picks. The company was a reliable cash generator … right up Buffett's alley.Buffett, through Berkshire Hathaway, still owns a big stake in Davita, but arguably wishes he didn't. Operating income turned unpredictable beginning in 2012, and in 2017 began to shrink more often than grow. That headwind has been reflected in the stock's price from the point in time it started to blow. * 10 High-Yielding Dividend Stocks That Won't Wilt Buffett and Berkshire appear to still be committed to the trade. Given the uncertain future the country's healthcare system faces though, on top of the trouble the company was facing even before such questions surfaced, there's no end in sight for the stock's net-bearishness.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 High-Yielding Dividend Stocks That Won't Wilt * 4 Energy Stocks Soaring as Trump Tightens on Iran * 7 Tech Stocks With Too Much Risk, Not Enough Upside Compare Brokers The post 10 Oversold Stocks to Run From appeared first on InvestorPlace.
Hasbro stock was up more than 15% after the toy maker swung to a surprise profit in its first quarter and beat sales estimates, too.
Hasbro's (HAS) first-quarter 2019 results were driven by robust performance of the U.S. and Canada segment as well as Entertainment, Licensing and Digital segment.
NEW YORK, NY / ACCESSWIRE / April 22, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review ...
Toys "R" Us liquidation, tighter retail inventory and soft consumer demand remain concerns for Mattel (MAT) in the first quarter of 2019.
NEW YORK, NY / ACCESSWIRE / April 18, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Mattel, Inc. ("Mattel" or the "Company") (MAT) and certain of its officers and directors. The class action, filed in United States District Court, Central District of California, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who acquired Mattel securities between February 7, 2019, and February 15, 2019, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act").
A 2018 survey of CEO pay in 22 countries around the world including the U.S. found that the average CEO was paid $3.55 million annually.Here in Canada, where I live, the average CEO was paid a little more than $7 million. In the UK, it was almost a million higher than Canada.How about the U.S.?InvestorPlace - Stock Market News, Stock Advice & Trading TipsWell, it was the number one country for CEO pay at $14.25 million -- or more than four times the global average. Are U.S. CEOs worth that much -- or that much more than CEOs in other countries? Not by a long shot. But that doesn't stop some professorial types from singing their praises."The efforts of America's highest-earning 1% have been one of the more dynamic elements of the global economy. It's not popular to say, but one reason their pay has gone up so much is that CEOs really have upped their game relative to many other workers in the U.S. economy," stated George Mason University Economics professor Tyler Cowen in his recent book Big Business: A Love Letter to an American Anti-Hero. CEOs might have a more complicated job than they had 20 years ago, but that doesn't justify pay that is 361 times the average U.S. rank-and-file worker. U.S. Congressman Keith Ellison released a report in 2018 that suggested a median employee at Mattel (NYSE:MAT) would have to work at the company for 495 years to earn as much as a CEO's annual pay. Ridiculous. Investors need only to consider one fact. "Since 2008, the 100 companies with the lowest CEO compensation within the S&P 500 index have outperformed the 100 with the highest compensation every year except 2013," Bloomberg reported in March of this year. "The annualized return from 2008 to 2018 was 17.2 percent compared with 8.4 percent."It is clear that investing in companies who are doing a good job cutting the gap between the CEO's pay and the average employee is key to your portfolio's future success. * The Jobs Report Isn't an Effective Metric for the U.S. Economy Here are seven stocks to buy in that vein. Intuitive Surgical (ISRG)Source: Jon Fingas via Flickr (Modified)CEO Pay: $5.1 millionPay Ratio: 32:1The median worker's pay at Intuitive Surgical (NASDAQ:ISRG) is $157,491, the 22nd highest amount of compensation in the S&P 500. It kind of makes sense. Do you really want a bunch of low-paid workers manufacturing the company's da Vinci surgical robotic systems? One wrong move and your hernia repair becomes a one-way ticket to the morgue. I'm facetious, but I think you get my meaning. By having well-paid employees, not only are they likely to be happier; they're probably more productive especially when they realize that the CEO makes just 32 times their pay, about one-tenth the U.S. average. Intuitive Surgical has come a long way from 1999 when it launched the first da Vinci system. At the end of 2018, it had almost 5,000 systems installed; 64% of them in the U.S. with Europe and Asia its next biggest markets, but with plenty of room to grow. The global surgical robotics market is expected to grow by almost 14% annually over the next seven years to $17 billion. ISRG currently has a 17% market share. If it grows that market share to 25% by 2025, it translates into an additional $1.4 billion in revenue. As people age, minimally invasive surgery will become even more critical than it already is. As secular trends go, ISRG is one of the best bets you can make. American Water Works (AWK)Source: Shutterstock CEO Pay: $4.4 millionPay Ratio: 53:1American Water Works (NYSE:AWK) CEO Susan Story is the only woman on this list so if ESG issues are of interest to you; AWK is an excellent stock to consider. As for its business, that's also good. AWK was recently named one of Barron's 100 Most Sustainable U.S. Companies. Also, Bloomberg included AWK on its list of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI), a group selected for their dedication advancing the cause of women. That's a big deal when you consider that providing equal pay for U.S. women would add $512 billion to the economy on an annual basis. Here's another reason to like the water utility. AWK stock hasn't had a single year with a negative total return delivering a 10-year annualized total return of 20.6%, which goes entirely against the theory that utilities are dull and poor performers over the long haul. * 5 Dividend Stocks Perfect for Retirees Providing water services to more than 14 million people in 46 states, AWK is a stock whose business will never go the way of the Dodo bird. Fastenal (FAST)Source: Shutterstock CEO Pay: $2.0 million Pay Ratio: 58:1If you've owned Fastenal (NASDAQ:FAST) for the past five years, your patience is finally being rewarded after spending four years rangebound between $40-$50. Up 32% year to date through April 15, FAST stock looks like its gallop to $100 is underway. Consider that the supplier of industrial and construction supplies grew revenues and operating profits over the past five years by 49% and 40% to $5.0 billion and $1.0 billion respectively. And for that, its stock went sideways. In the company's Q1 2019 earnings, Fastenal grew the top and bottom lines by double digits. Revenues were up 12.2% on a like-for-like basis, and net earnings rose 11.9% to $0.68 a share. Helping move the needle is its industrial vending machine program. In the first quarter, it signed 5,603, bringing the total number to 83,410, an increase of 13.4% over Q1 2018. Sales at those machines grew in the high teens in the first quarter. And you thought vending machines were a thing of the past. Fastenal is all about customer service. It's got the growth to prove it. Amazon (AMZN)Source: Shutterstock CEO Pay: $1.7 millionPay Ratio: 59:1Say what you will about Amazon (NASDAQ:AMZN) CEO and founder Jeff Bezos, but you can't deny his company's success. A $10,000 investment ten years ago is worth almost $247,000 today. Bezos might be amoral or immoral in your opinion but his ability to deliver what the world's craving is astonishing. Everything Amazon does is to please the customer. In Bezos' annual letter to shareholders, he mentions the word customer on 49 occasions. "Much of what we build at AWS is based on listening to customers. It's critical to ask customers what they want, listen carefully to their answers, and figure out a plan to provide it thoughtfully and quickly (speed matters in business!). No business could thrive without that kind of customer obsession. But it's also not enough. The biggest needle movers will be things that customers don't know to ask for," the CEO wrote. * 7 Stocks to Buy for Spring Season Growth How many CEOs do you know that think like this? I can count the number on two hands. He might be an a**hole in the minds of many, but he's a brilliant one, cut from the same cloth as Elon Musk. Garmin (GRMN)Source: slgckgc via Flickr (modified)CEO Pay: $2.4 millionPay Ratio: 76:1The cream always rises to the top. Garmin (NASDAQ:GRMN) is one of those companies that seems to fly under the radar despite being a reasonably large company. If you own Fitbit (NASDAQ:FIT) stock, however, you're likely more than a little aware of Garmin. In the most recent quarter, Garmin delivered boffo earnings. Since announcing Q4 2018 results February 20, GRMN stock is up 24%. A key highlight from earnings was its guidance for 2019. Analysts were expecting earnings of $3.52 a share on $3.43 billion in revenue. Garmin CEO Cliff Pemble's outlook is for $3.70 a share on the bottom line and $3.50 billion on the top line. "2018 was another remarkable year of revenue and operating income growth driven by strong performance in our aviation, marine, outdoor and fitness segments," Pemble said in its news release. "Entering 2019, we see many opportunities ahead and believe that we are well positioned to seize these opportunities with a strong lineup of products across all of our segments."Hopefully, you're beginning to see a trend. Companies that keep the pay ratio low tend to deliver strong long-term results. Since Pemble became CEO in January 2013, GRMN stock has generated a 19.7% annualized total return for shareholders, 440 basis points greater than the SPDR S&P 500 ETF (NYSEARCA:SPY). Simon Property (SPG)Source: m01229 via Flickr (Modified)CEO Pay: $4.8 million Pay Ratio: 88:1A lot of investors might have a problem owning shopping malls. I certainly wouldn't. But they've got to be good. They can't be Class C malls with no-name retailers filling the place. That's a recipe for disaster. Zacks recently wondered if Simon Property's (NYSE:SPG) efforts were enough to battle the retail blues. Are we seriously still having that discussion in 2019. Well, it turns out there are a lot of crappy retailers still operating including Sears. "The deepening of the relationship with existing tenants, and the launch of its online retail platform, weaved with an omni-channel strategy, will likely be accretive to Simon Property's long-term growth," wrote Zack's equity research team April 8."In fact, the company is investing billions and actively restructuring its portfolio, aiming at premium acquisitions and transformative redevelopments. The transformational plans include the addition of hotels, restaurants, residences and luxury stores."The fact is, very few retail mall owners have the vision of the Simon family. They've been doing this a long time. They're more than capable of rolling with the punches. * 10 S&P 500 Stocks to Weather the Earnings Storm Good brick-and-mortar retail isn't disappearing. Just the crappy kind is. Know the difference. O'Reilly Automotive (ORLY)Source: JJBers via Flickr (modified)CEO Pay: $2.9 millionPay Ratio: 141:1O'Reilly Automotive (NASDAQ:ORLY) makes it on to the list despite hitting a 26-year high of $398.41 in early April and carrying on past $400 in the days that followed. Up 19% year to date through April 15, ORLY's only had one year of negative returns since 2009. As a result, you're looking at a 10-year annualized total return of 27.3%, almost double the S&P 500. In 2018, the retailer of aftermarket auto parts had same-store sales growth of 3.8%, at the top of its estimate for the year, the company's 26th year with an increase. In 2019, it expects same-store sales growth of 3%-5%. This past year it opened 200 net new stores in 36 states. It plans to open as many as 210 in 2019. It now has 5,219 stores across the U.S. On the bottom line, O'Reilly increased its EPS by 27% over 2017 to $16.10, the 10th consecutive year with a 15% increase in earnings. In 2019, it expects EPS of at least $17.37. Given its track record, you should expect more than that. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post 7 Companies That Are Closing the CEO-Worker Wage Gap appeared first on InvestorPlace.
Mattel (MAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, April 18, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals.
Mattel and the Consumer Product Safety Commission have voluntarily recalled the Rock ‘N Play, which is tied to a number of infant deaths.
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mattel, Inc. ("Mattel" or the "Company") (MAT) of the May 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Mattel stock or options between February 7, 2019 and February 15, 2019 and would like to discuss your legal rights, clickhere: www.faruqilaw.com/MAT.
Stocks that moved substantially or traded heavily on Monday: Electronics For Imaging Inc., up $8.60 to $38 The digital printing company is being bought by private equity firm Siris Capital Group LLC for ...
The company, in cooperation with the U.S. Consumer Product Safety Commission, issued a recall notice for the Rock ‘n Play Sleeper after reports that over a 10-year period more than 30 infants suffocated or strangled when they rolled over in the sleepers while unrestrained. Mattel says the deaths were the result of improper use, and that it stands by the safety of its products, though it agrees the best course of action right now is to recall the sleepers. On top of that, Johnson expects Fisher-Price will lose about $35 million in sales for the rest of the year.
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
Mattel Inc.'s reputation is at risk after a recall of the Fisher-Price brand Rock 'N Play, Stifel analysts say. Both Mattel and the Consumer Product Safety Commission (CPSC) have warned consumers that infants can roll over in the item. The Rock 'N Play has been tied to 10 infant deaths since 2015, according to the CPSC. "We stand by the safety of our products," Chuck Scothon, general manager of Fisher-Price, said in a statement Friday. "However, due to reported incidents in which the product was used contrary to the safety warnings and instructions, we have decided to conduct a voluntary recall of the Rock 'n Play Sleeper in partnership with the Consumer Product Safety Commission." Stifel analysts think the recall poses legal risk to Mattel, could lead to manufacturing and design costs, and could drive up marketing costs. "Product recalls, while less frequent, are part of the toy business," Stifel said. "But they pose reputation risk and may undermine licensor, retailer, and consumer confidence in the safety of a product or brand, lead to litigation and increased compliance costs, all of which could have a negative influence on the industry and/or a toy manufacturer's business." Stifel rates Mattel shares hold with a $14 price target. Mattel is scheduled to report first-quarter earnings on April 25. The Fisher-Price brand has struggled, analysts say. Mattel stock, on the other hand, has rallied 36.1% for 2019 so far, outpacing the S&P 500 index , which is up 16% for the period.